AIDS Nonprofit Says BMS Overcharged For Drugs

Law360, New York (November 30, 2010, 6:39 PM EST) -- Bristol-Myers Squibb Co. is under fire from an AIDS nonprofit alleging the pharmaceutical giant breached an agreement by overcharging for drugs that should have been discounted as part of the health care overhaul.

The complaint, filed last Wednesday in the U.S. District Court for the Central District of California, claims that Bristol-Myers failed to promptly lower drug prices for nonprofit and governmental medical providers as required by the new health care law, overcharging the AIDS Healthcare Foundation by more than $124,000.

The Patient Protection and Affordable...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.